chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had Anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Had Anxiety) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical hisory were reported.  Concomitant products included ANXIETY & STRESS for Anxiety, ACETYLSALICYLIC ACID, ASCORBIC ACID (ASPIRIN-C) and ATORVASTATIN for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ANXIETY (Had Anxiety). At the time of the report, ANXIETY (Had Anxiety) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included acid reflux.  Treatment details not reported.
My kidney results were stable in March. The next time I did the kidney labs on August 2nd, 2021 it had more than doubled. Clearly my disease was progressing. Then I did telehealth with Dr. on 08/11/2021.  I  changed my diet and took the test again.  I dropped off my jug  on 09/03/2021 in the morning, I received my 3rd Pfizer shot that afternoon.
Initial report received on 31 January 2013 from a manufacturer, which was reported by a healthcare professional, under (Manufacturer (MFR) report number: 1-6098105575). An adult female patient received an injection of MENACTRA, sanofi pasteur Inc. (also reported as manufacturer unspecified) (lot number, route, site, dose in series not reported) on an unspecified date in 2010. On an unspecified date, the patient developed Pericarditis (time frame development of the Pericarditis was unspecified) following vaccination. The patient was hospitalized for an unspecified time frame and reported to be recovered, exact date of recovery unspecified. The patient's past medical history was not reported. Laboratory or diagnostic testing or treatments were not reported. The reporter and physician were not involved when vaccine was administered or during the development of the pericarditis and did not wish to be contacted for follow-up. Treating physician associated with the pericarditis was unspecified. No other information was reported. The patient's outcome was reported as recovered on an unspecified date. Documents held by sender: None.
This 17 year old was given the Moderna brand covid vaccination. He should have received the Pfizer brand since he is under 18.  No side effect or adverse event noted. Parent was notified.
my arm, where the injection was placed had a red circle about the size of a quarter and had a lump; my arm, where the injection was placed had a red circle about the size of a quarter and had a lump; left upper arm where injection was administered started to hurt in the muscle and surrounding areas/the pain is still intense while sleeping; left upper arm where injection was administered started to hurt in the muscle and surrounding areas/the pain is still intense while sleeping; This is a spontaneous report from a contactable consumer. A 74-years-old male patient received  bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 at 11:30 as Dose 2, Single for covid-19 immunization. Medical history none, patient was in excellent condition. The patient's concomitant medications were not reported. Historical vaccination the patient received first dose of bnt162b2, administered in Arm Left on 08Feb2021 11:30 (at the age of 74-year-old) as dose 1, single for covid-19 immunisation with no adverse reaction. The patient was not received any vaccine in four weeks. The patient had no covid prior to vaccination nor been tested positive post vaccination. The patient had no known allergies.On 01Apr2021, after 4 weeks of 2nd Pfizer Covid 19 shot, the patient stated that his left upper arm where injection was administered started to hurt in the muscle and surrounding areas. Very painful when turning my arm in certain positions. Been like this for at least a month. Last week my arm, where the injection was placed had a red circle about the size of a quarter and had a lump. After 3 days later it was gone however, the pain is still intense while sleeping. Therapy for the events included taking 600 mg of ibproferon so he could sleep and Heat packs on upper left muscle area. On an unknown date, the patient had recovered from the events injection was placed had a red circle about the size of a quarter and had a lump while the outcome of the other events was not recovered.  No follow up attempts were possible; Information about lot/batch number cannot be obtained. No further information was expected.
On June 30,2021 I began to experience heart palpitations that lasted an hour or so, and I would have shortness of breath. These symptoms would come and go and lasted for a month. I went to  the Urgent Care on July 29, 2021 where I was advised by the doctor to take magnesium and potassium after having an EKG test run.
8SEP92 pt got up in the morning w/t99.6, very puffy upper & lower eys lids, & rash on face & neck; the rash worsened during the day spreading to the thighs; 9SEP92 eyes were better & rash was fading;
Pt was seen in office for a follow up URI. Pt was administered a flu vaccine at this time. Came back to office 11/12/08 for a pretty significant reaction.
Erythema left upper arm (7 cm x 8 cm). Swelling, warmth. Headache, nausea. Low grade fever, pain to left upper arm.
no adverse event; second dose in 2019, and the last dose in july 2022; Caller is a consumer who stated that she received all three doses of GARDASIL 9, but they were all taken several years apart outside of the recommended dosage scheduling; This spontaneous report was received from a consumer reporting on herself, a 25-year-old female patient.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date in August 2015, the patient was vaccinated with the first dose of 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) (strength, dose, anatomical location, route of administration, lot #, and expiry date were not reported).On an unspecified date in June 2019, the patient received the second dose of 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) (strength, dose, anatomical location, route of administration, lot #, and expiry date were not reported)(Inappropriate schedule of vaccine administered). On an unknown date in July 2022, she was vaccinated with the 3rd dose of 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) (strength, dose, anatomical location, route of administration, lot #, and expiry date were not reported), all doses were given as prophylaxis (Inappropriate schedule of vaccine administered). No adverse event was reported.
The patient received a partial dose of Imovax, during administration, the syringe leaked around where the needle attaches to the syringe and discontinued giving the dose before the total amount went in because it was "dripping on the floor"; The patient received a partial dose of Imovax, during administration, the syringe leaked around where the needle attaches to the syringe and discontinued giving the dose before the total amount went in because it was "dripping on the floor"; Initial information received on 18-Jul-2019 regarding an unsolicited valid non-serious case received from a Nurse.  This case involves a 27 years old female patient who received a partial dose of RABIES (HDC) VACCINE [IMOVAX RABIES] vaccine while administering it the syringe leaked around where the needle attaches to the syringe and discontinued giving the dose before the total amount went in because it was dripping on the floor lot P1C851M, Expiration Date: 25-Sep-2020 via intramuscular route in deltoid administration site on 18-Jul-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history and concomitant therapies were not provided.   It was an actual medication error due to inappropriate dose of vaccine administered.  It was also a case of syringe issue.  Adverse event was not reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
seizure; This case was reported by a consumer via interactive digital media and described the occurrence of seizure in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, less than an hour after receiving Bexsero, the patient experienced seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the seizure was unknown.   It was unknown if the reporter considered the seizure to be related to Bexsero.  Additional details were received as follows: This case was received from patient's parent. The age at vaccination was not reported. The patient experienced seizure within 10 minutes of Bexsero vaccination.  The reporter was the only witness.  The physician refused to believe that, it was a seizure.  The reporter reported, it was scary.
Return of stiffness and pain at the injection site; at the time of this report the stiffness and pain has returned for 13 hours; pain is not severe but hindered sleep
Hives, for a week. Finally the doctors office had to give a steroid shot.  For the week he was given Benadryl and steroid treatment orally.  The shot was the last resort.
pain in the injection arm; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 57-year-old male patient who received Herpes zoster (Shingrix) (batch number 2K9T2, expiry date 9th April 2022) for prophylaxis.   On 28th January 2020, the patient received the 2nd dose of Shingrix. On 28th January 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows:  The patient experienced pain in the injection arm after receiving the dose of Shingrix, that increased and continued until the time of reporting. The reporter consented to follow up.
Headache, body aches, fever for 3 days. Ibuprofen for treatment. Patient still experiencing headache with no relief
I still have pain in my neck, wrists, groin and hands from arthritis brought on by LYMERIX vaccine.
On 01/08/2022- I woke up scratching my scalp and on my torso as well, I felt like I had some itchy powder. I had really, really dry skin. I had red welts, with intense itching and redness that would appear around the welt. My face, scalp torso, hand, toes, fingers, legs, all the sensitive areas of my body. It responds to touch. If I scratch or touch anything the welts and redness will appear at that point, and it does not fade until I ignore it and stop itching it. I started taking 25 Benadryl every 4 hours that afternoon. And I have been taking that dose as of today. I also took a COVID-19 test that afternoon and the result was negative. I saw the doctor on 01/11/2022- she prescribed prednisone 6 days worth, front loaded, so you take 6, then 5, etc. That did not appear to have any affect whatsoever. I continue the Benadryl 25 mg every 24 hours, that is pretty much the only thing that takes the edge. She diagnosed me with hives and it appears to be an allergic reaction to something. No, I have not recovered from the AE, it is persisting. I have an appointment tomorrow, 01/18/2022.
Pt contacted Health Dept. on 11-4-2013 stating received a flu vaccine on 10-23-2013 in her left arm.  Began having pain in L arm almost immediately and the pain has gotten worse.  She now has some tingling in her fingers.  She has been icing it and taking pain meds for it. Has not seen a physician.  Encouraged to see a physician.  Saw her Primary Care Physician on 11/5/2013.  After examining her arm the Dr. told her that a nerve was hit when the shot was administered.  She was told this happens sometimes.  Treated with a Medrol Dose Pack and Keflex for 3 days. Already feels better today.
This spontaneous report as received from a physician refers to an adult patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with RECOMBIVAX HB, 40 mcg (route of administration, lot # and expiry date were not provided) for prophylaxis. The physician reported that she gave an adult (non dialysis) patient a 40 mcg dose of RECOMBIVAX HB (incorrect dose administered). No adverse symptoms reported.
Blurred vision and high blood pressure at the time of the vaccine.; Blurred vision and high blood pressure at the time of the vaccine.; Stomach pain with Hives; Stomach pain with Hives; loss of the right ear and numbness on the right side with shortness of breath as if she were congested; loss of the right ear and numbness on the right side with shortness of breath as if she were congested; loss of the right ear and numbness on the right side with shortness of breath as if she were congested; This is a spontaneous report from a contactable consumer (patient).  A 50-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 24Mar2021 12:00 (Batch/Lot number was not reported) age at vaccination of 50-years-old, as single dose, for covid-19 immunisation.  Medical history included diabetes mellitus from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing (Oxycodon). The patient was not pregnant and was not pregnant at the time of vaccination. Concomitant medications included ibuprofen (IBUPROFEN) taken for an unspecified indication, start and stop date were not reported; pioglitazone hydrochloride (ACTOS) taken for an unspecified indication, start and stop date were not reported; glipizide (GLIPIZIDE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Apr2021 the patient experienced blurred vision and high blood pressure, stomach pain with hives, loss of the right ear and numbness on the right side with shortness of breath as if she was congested. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care; the patient was hospitalized for 3 days and the events were also considered serious as disability. The patient was treated with cortisone to restore hearing.  The patient underwent lab tests and procedures which included sars-cov-2 test unknown results on 28May2021, sars-cov-2 test negative on 26May2021 (Nasal Swab), sars-cov-2 test unknown results on 28May2021 (Nasal Swab). Outcome of the events was unknown.  Information on the lot/batch number has been requested.
On 4/29: 6pm - fatigue, 9pm - more fatigue and aching joints On 4/30: 2am - very warm body (not quite feverish), very minor chills, fatigue, extremely aching joints, muscle weakness, frontal lobe headache that persisted until 7am (ibuprofen taken at 6:40am), brain fog that persisted until noon (possibly due to lack of sleep) 3 doses of Ibuprofen throughout 4/30 helped symptoms to subside 5/1: morning - woke up feeling no symptoms whatsoever, slept wonderfully Evening - some aching and fatigue set in around 9-10pm, took 1 dose ibuprofen at 10pm 5/2: morning - woke up feeling no symptoms again
administration of only the liquid component of Menveo; administration of only the liquid component of Menveo; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: administration of only the liquid component of Menveo) and inappropriate dose of vaccine administered (Verbatim: administration of only the liquid component of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 19-JUL-2023 The healthcare professional asked for guidance on this situation. The reporter did not provide patient information nor data about the dose of Menveo (lot number, expiry date). The reporter consented to follow up. The reporter called to report that the administration of only the liquid component of Menveo to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Patient was observed for 15 minutes after the injection time. Patient left with her daughter to the car and while she was in the car she had a vasovagal syncope. This last for couple seconds. Vital signs were stable except for her pulse Ox at RA was 80%. The ambulance was called and the EMT kept patient on the ambulance monitoring her vital signs.
Woke up in middle of night with headache. Thought maybe tired from getting up early but have had fatigue and muscle aches (lower back, arms, ankles, head, chest). Been tired through the day...not so bad that I was unable to work. Took Tylenol and that helped lower the body aches...but only lasted 4-6 hours.
Nasal congestion, sinus pressure, burning in my sinus, loss of taste, loss of smell. Headache, body ache, shortness of breath. Tested positive to COVID-19 test.
Face paralysis; Bells palsy; Incomplete course of vaccination; This case was reported by a consumer via media and described the occurrence of facial paralysis in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced facial paralysis (serious criteria GSK medically significant), bell's palsy (serious criteria GSK medically significant) and incomplete course of vaccination. On an unknown date, the outcome of the facial paralysis and bell's palsy were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the facial paralysis and bell's palsy to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient's child. The age at vaccination was not reported. The patient received single dose of shingles vaccine years ago and experienced facial paralysis. Within days, the patient experienced bell's palsy. Till the time of reporting, patient did not receive 2nd dose of shingles vaccine, which led to incomplete course of vaccination. This case has been linked with the case US2021AMR176003, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR176003:Dad's case
Left thigh increased redness the night of the immunization (7-12-11) at 10 pm. Was given OTC TYLENOL, c/o thigh pain & warmth, acting fine. No temp, NVD. Reaction was 170 x 140 cm (L) thigh 7-14-11.
Dose 1 received 07/30/2021. Dose 2 received 08/20/2021. Dose 3 (booster) received 05/11/2022.  Prior to my first dose, my thyroid (TSH) was slightly elevated at 7.84.  After Dose 1 and 2, at my next test a few months later, my TSH had nearly tripled to 20  never been that high.  Nothing else had changed in my diet or routines.  My appetite was the same, but I gained 4 lbs (138 to 142).  The further I've gotten from my booster, by late 2022, my weight returned to 138, and my TSH has been dropping back toward acceptable range.  At the very minimum, if the Pfizer vax did not cause the TSH spike, it at least magnified what might have been a small spike from something else.
I was given the shot and instantly, my arm started bleeding. He asked me if I have had this happen to me before, and I told him that I had never experience a reaction to any shot. The next day, arm started hurting.
Initial report received from a nurse on 16 Dec 2009: This patient was vaccinated with FLUVIRIN (batch:1008142P) intramuscular on 14 Dec 2009. One dose of this vaccine was given to 3 years old boy. No adverse effect was noted after administration.
Patient stated she had normal muscle soreness for approx. 1 day post vaccine. 2 days later area began to have a periodic dull pain that has continued to recur 30 days post vaccine. No redness, swelling, or visible problems.
Swollen, red, indurated arm-told to use Tylenol per mouth and cold packs.
Severe depression; Vaccine hit them hard; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (Severe depression) and VACCINATION COMPLICATION (Vaccine hit them hard) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEPRESSION (Severe depression) and VACCINATION COMPLICATION (Vaccine hit them hard). At the time of the report, DEPRESSION (Severe depression) and VACCINATION COMPLICATION (Vaccine hit them hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not provided. Treatment information was not reported.
Information has been received from a registered nurse concerning a 15 year old male who was vaccinated with a dose VARIVAX (Merck). On 09-Apr-2008 the patient had chickenpox. No documentation of the child's vaccination with the vaccine because the child could have received the vaccine from another doctor's practice. Unspecified medical attention was sought, in the doctor's office. There was no product quality complaint. Follow up information received 08-APR-2008. The patient did not have any adverse event after he received  VARIVAX (Merck). Follow up information received on 14-Apr-2008. Someone from the physician office indicated that, they did not have records of the patient receiving VARIVAX (Merck). The mother did not provide immunization records for the patient. Follow-up information received from the physician it was reported "No adverse events after vaccine". Additional information is not expected.
Having lower abdominal pain and cramping in the left in the lower abdomen area. Colonoscopy clear. I had a biopsy on part of colon that was prolapsed, they did a biopsy and that was clear. They sent me for a CT scan, showed multiple tumors throughout my pelvic abdomen region. Around the colon and female organs. I went to go see Dr. (Gynecologist/Oncologist) and he will be doing the surgery to remove them and possibly a hysterectomy. And we'll see if they're cancerous or something else. And they still hurt.
Radiating pain from injection site starting 3-4 hours post injection. Intense pain x 3 days. Pain has gotten better over time, but still has significant pain (27 days post injection).